glp 1 receptor antagonist drugs GLP-1 Agonists: An Alternative for Rapid-Acting Insulin? How GLP-1 medications are transforming
Description
Like any medication, they carry risks, but most are mild and manageable
Nonetheless, for new GLP-1 drugs in development, it is imperative to evaluate potential drug interactions since this drug class can alter the efficacy of concomitant medications or increase the risk of adverse events as a result of higher exposure to a co-administrated drug
Transdermal Drug Delivery Systems (TDDS) Transdermal drug delivery systems (TDDS) are non-invasive methods of drug delivery through the skin
10.1016/j.mce.2010.04.022 [DOI] [PubMed] [Google Scholar] 193.Fadini GP, Avogaro A
Evans, S
About one-third of patients achieved 25% or greater weight loss
